Zhong-hua D. Wang
270 Dong An Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N.
Journal: Cell reports. Medicine
Published: February 04, 2026
Integrated genomic profiling identifies predictive biomarkers for neoadjuvant therapy response in Chinese breast cancer patients.
Journal: Cancer letters
Published: February 03, 2026
Effect of adjuvant carboplatin intensified chemotherapy versus standard chemotherapy on survival in women with high risk, early stage, triple negative breast cancer (CITRINE): randomised, open label phase 3 trial.
Journal: BMJ (Clinical research ed.)
Published: December 23, 2025
Interferon-induced senescent CD8+ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer.
Journal: Science translational medicine
Published: September 10, 2025
CD8-guided immunochemotherapy improves pathological complete response rates in high-tumor-burden triple-negative breast cancer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 14, 2025
Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial).
Journal: Molecular cancer
Published: April 28, 2025
Temporal trends in breast cancer treatment patterns and survival: A comprehensive analysis of the SEER database from 1990 to 2017.
Journal: Current problems in surgery
Published: April 03, 2025
Efficacy and safety of inetetamab plus pertuzumab and nab-paclitaxel as neoadjuvant therapy for HER2+ breast cancer: A single-arm multicenter phase II clinical trial.
Journal: Cancer letters
Published: March 11, 2025
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2- breast cancer: The LINUXtrial.
Journal: Cancer cell
Published: March 08, 2025
Tumor evolution: signaling pathways, molecular mechanisms and therapeutic targets.
Journal: Signal transduction and targeted therapy
Published: February 24, 2025
Leptomeningeal metastasis in triple-negative breast cancer: a retrospective study.
Journal: Discover oncology
Published: February 05, 2025
Comprehensive genomic profiling of triple-negative breast cancer metastases identifies role of PKD1 in immunotherapy resistance.
Journal: The Journal of clinical investigation
Published: November 18, 2024
Last Updated: 09/26/2026